Lisa Geertjens

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Potential benefits of l-serine in children with GRIN2B loss-of-function variants: Randomized n-of-1 trials.

Potential benefits of l-serine in children with GRIN2B loss-of-function variants: Randomized n-of-1 trials.

Journal: Molecular genetics and metabolism

Published: March 19, 2025

Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233].

Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233].

Journal: Contemporary clinical trials communications

Published: March 27, 2024

Mechanism-based interventions for ASD cannot be implemented using conventional trial designs.

Mechanism-based interventions for ASD cannot be implemented using conventional trial designs.

Journal: Autism research : official journal of the International Society for Autism Research

Published: October 26, 2023

Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.

Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.

Journal: BMC psychiatry

Published: July 27, 2023

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials.

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials.

Journal: Contemporary clinical trials communications

Published: July 04, 2023

Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders.

Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders.

Journal: Genes

Published: December 28, 2021

Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol.

Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol.

Journal: BMC psychiatry

Published: December 03, 2021

Assessing the landscape of STXBP1-related disorders in 534 individuals.

Assessing the landscape of STXBP1-related disorders in 534 individuals.

Journal: Brain : a journal of neurology

Published: March 30, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026